The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden have?
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden has 3 citations in the OpenAlex counts ScholarIQ stores.
When was The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden published?
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden has 2025 year in the ScholarIQ index.
What is the open-access status of The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden?
The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden has hybrid oa status in the ScholarIQ index.
What is the DOI of The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden?
The DOI for The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden is on the source record.
What is the PMID of The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden?
The PMID for The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden is on the source record.
What is the OpenAlex record for The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden?
The OpenAlex for The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden is on the source record.